Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | CES2 | O00748 | 1/20 | 0.43 |
| ▸ | CES1 | P23141 | 1/20 | 0.43 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.43 |
| ▸ | PPARG | P37231 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.41 |
| ▸ | GSK3B | P49841 | 1/20 | 0.41 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.41 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.41 |
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL707474 | 0.85 | GPR35 (0.47) | NPSR1CES2POLBGAAALDH1A1 | |
| SCHEMBL14638979 | 0.83 | CES2 (0.47) | CES2CES1MAPTPTPN1GSK3B | |
| SCHEMBL28399426 | 0.83 | MAPT (0.50) | NPSR1CES2CES1EPHX2PPARG | |
| SCHEMBL25380495 | 0.83 | POLB (0.49) | EPHX2PPARGPOLBSMN1; SMN2NPC1 | |
| SCHEMBL28321122 | 0.83 | SMN1; SMN2 (0.45) | CES2CES1POLBSMN1; SMN2NPC1 | |
| SCHEMBL29001221 | 0.81 | CA1 (0.56) | NPSR1SMN1; SMN2NPC1RAB9AGAA | |
| SCHEMBL12398654 | 0.81 | CES2 (0.44) | CES2CES1PPARGMAPTALDH1A1 | |
| SCHEMBL17338792 | 0.80 | KMT2A (0.50) | NPSR1CES2CES1NPC1RAB9A | |
| SCHEMBL31258015 | 0.80 | KMT2A (0.44) | NPSR1POLBSMN1; SMN2GAAMAPT | |
| SCHEMBL28783011 | 0.80 | SMN1; SMN2 (0.49) | NPSR1CES2CES1SMN1; SMN2GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116082237-A | Nitrogen-containing heterocyclic compound and preparation method thereof | 安徽中医药大学 | 2023-05-09 | — | — | CN | disclosed |
| CN-111116368-B | Green preparation method of aryl alpha-keto acid ester compound | 河南师范大学 | 2022-07-22 | — | — | CN | disclosed |
| CN-111116368-A | Green preparation method of aryl α -keto acid ester compound | 河南师范大学 | 2020-05-08 | — | — | CN | disclosed |
| US-20160115508-A1 | PARTHENOLIDE DERIVATIVES, METHODS FOR THEIR PREPARATION AND THEIR USE AS ANTICANCER AGENTS | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2016-04-28 | — | — | US | disclosed |
| EP-3003317-A2 | PARTHENOLIDE DERIVATIVES, METHODS FOR THEIR PREPARATION AND THEIR USE AS ANTICANCER AGENTS | University Of Rochester (US) | 2016-04-13 | — | — | EP | disclosed |
| WO-2014197591-A2 | PARTHENOLIDE DERIVATIVES, METHODS FOR THEIR PREPARATION AND THEIR USE AS ANTICANCER AGENTS | UNIVERSITY OF ROCHESTER (US) | 2014-12-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160115508-A1 | PARTHENOLIDE DERIVATIVES, METHODS FOR THEIR PREPARATION AND THEIR USE AS ANTICANCER AGENTS | CYP3A43, POR, CYP3A4 | NPSR1 4392/4885CES2 98/4885CES1 107/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.